Your search history is turned on.
Date: March 12, 2024 Jurisdictions: Ontario, Quebec
GAB0400_NSRP_Revocation_Procedure_Simplifiee_Regime_Double Place de la Cit, tour Cominar 2640, boulevard Laurier, bureau 400 Qubec (Qubec) G1V 5C1 Tlphone : 418 525-0337 Tlcopieur : 418 525-9512 Numro sans frais : 1 877 525-0337 www.lautorite.qc.ca 800, rue du Square-Victoria, bureau 2200 Montral (Qubec) H3C 0B4 Tlphone : 514 395-0337 Tl...
Date: February 16, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
20240216_Notice_Change NOTICE OF CHANGE IN CORPORATE STRUCTURE (pursuant to section 4.9 of NI 51-102) 1. Name of the parties to the transaction Mirati Therapeutics, Inc. (the Company), Bristol-Myers Squibb Company (BMS) and Vineyard Merger Sub Inc., a wholly-owned subsidiary of BMS (Merger Sub). 2. Description of...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2024 MIRATI THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35921 46-2693615 (State of incorporati...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2023 MIRATI THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35921 46-2693615 (Sta...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriat...
Date: November 7, 2023 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Mirati Therapeutics, Inc. 3545 Cray Court San Diego, California 92121 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS TO BE HELD VIRTUALLY VIA THE INTERNET ON DECEMBER 13, 2023 Notice is hereby given that a special meeting of stockholders (including any adjournments or postponements thereof, which we refer to as the Special Meeting) of Mirati Therapeutics, Inc., a Delaware corpora...
Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLYTHIS PROXY CARD IS VALID ONLY WHEN SIGNED. V25369-S76470 3. To approve the adjournment of the special meeting to a later date or dates, if necessary or appropriate, to solicit...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of...